Literature DB >> 21918988

Supersaturation-nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms.

Shunsuke Ozaki1, Takuma Minamisono, Taro Yamashita, Takashi Kato, Ikuo Kushida.   

Abstract

In order to better understand the oral absorption behavior of poorly water-soluble drugs, their supersaturation-nucleation behavior was characterized in fasted state simulated intestinal fluid. The induction time (t(ind)) for nucleation was measured for four model drugs: itraconazole, erlotinib, troglitazone, and PLX4032. Supersaturated solutions were prepared by solvent shift method, and nucleation initiation was monitored by ultraviolet detection. The relationship between t(ind) and degree of supersaturation was analyzed in terms of classical nucleation theory. The defined supersaturation stability proved to be compound specific. Clinical data on oral absorption were investigated for drugs in thermodynamically high-energy forms such as amorphous forms and salts and was compared with in vitro supersaturation-nucleation characteristics. Solubility-limited maximum absorbable dose was proportionate to intestinal effective drug concentrations, which are related to supersaturation stability and thermodynamic solubility. Supersaturation stability was shown to be an important factor in determining the effect of high-energy forms. The characterization of supersaturation-nucleation behavior by the presented method is, therefore, valuable for assessing the potential absorbability of poorly water-soluble drugs.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918988     DOI: 10.1002/jps.22760

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Drug-drug interaction potential of marketed oncology drugs: in vitro assessment of time-dependent cytochrome P450 inhibition, reactive metabolite formation and drug-drug interaction prediction.

Authors:  Jane R Kenny; Sophie Mukadam; Chenghong Zhang; Suzanne Tay; Carol Collins; Aleksandra Galetin; S Cyrus Khojasteh
Journal:  Pharm Res       Date:  2012-03-14       Impact factor: 4.200

2.  Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state.

Authors:  Sneha Rathi; Rahul B Chavan; Nalini R Shastri
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

3.  Improving solubility and oral bioavailability of a novel antimalarial prodrug: comparing spray-dried dispersions with self-emulsifying drug delivery systems.

Authors:  Suresh Potharaju; Shravan Kumar Mutyam; Mingtao Liu; Carol Green; Lisa Frueh; Aaron Nilsen; Sovitj Pou; Rolf Winter; Michael K Riscoe; Gita Shankar
Journal:  Pharm Dev Technol       Date:  2020-02-12       Impact factor: 3.133

4.  Combined use of crystalline sodium salt and polymeric precipitation inhibitors to improve pharmacokinetic profile of ibuprofen through supersaturation.

Authors:  Jenna L Terebetski; John J Cummings; Scott E Fauty; Bozena Michniak-Kohn
Journal:  AAPS PharmSciTech       Date:  2014-06-12       Impact factor: 3.246

Review 5.  Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.

Authors:  Hywel D Williams; Natalie L Trevaskis; Yan Yan Yeap; Mette U Anby; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-07-04       Impact factor: 4.200

6.  An Insight into Eudragit S100 Preserving Mechanism of Cinnarizine Supersaturation.

Authors:  Maryam Maghsoodi; Saeideh Mollaie Astemal; Ali Nokhodchi; Hossein Kiaie; Ali Baradar Khoshfetrat; Fatemeh Talebi
Journal:  AAPS PharmSciTech       Date:  2022-03-01       Impact factor: 3.246

7.  Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways.

Authors:  Khadijah Edueng; Denny Mahlin; Per Larsson; Christel A S Bergström
Journal:  J Control Release       Date:  2017-04-12       Impact factor: 9.776

8.  Enabling formulations of aprepitant: in vitro and in vivo comparison of nanocrystalline, amorphous and deep eutectic solvent based formulations.

Authors:  Henrik Palmelund; Jonas B Eriksen; Annette Bauer-Brandl; Jukka Rantanen; Korbinian Löbmann
Journal:  Int J Pharm X       Date:  2021-06-05

9.  Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures.

Authors:  Min-Soo Kim
Journal:  Int J Nanomedicine       Date:  2013-05-20

10.  Direct Measurement of Amorphous Solubility.

Authors:  Jernej Štukelj; Sami Svanbäck; Mikael Agopov; Korbinian Löbmann; Clare J Strachan; Thomas Rades; Jouko Yliruusi
Journal:  Anal Chem       Date:  2019-05-14       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.